Skip to main content
SpringerLink
Log in

Botulinum toxin A treatment of the lower extremities in children with cerebral palsy

  • Current Concept Review
  • Published:
Journal of Children's Orthopaedics

Abstract

Objectives

In the last 2 decades, BTX-A is increasingly being used in the management of spasticity in children with Cerebral Palsy (CP) and there is no doubt about its effect on range of motion, spasticity reduction and gait pattern in this patient population. However, in daily practice, there is still an ongoing search for the best way to apply BTX-A. Two studies were set up to evaluate how successful an integrated multilevel treatment approach is in children with CP. The first study identifies crucial factors within the treatment strategy which may predict the outcome. The second study evaluates the efficacy of repeated BTX-A injections.

Methods

Patient selection was based on following criteria: diagnosis of CP, lower limb BTX-A treatment, age at time of treatment <24 years, no combined surgery at the time of BTX-A injections, 3D gait analysis and clinical evaluation pre and 2 months post BTX-A injections. The first study included the last treatment of 577 patients. In the second study, the first and last BTX-A treatment of 222 children were included. The Goal Attainment Scale (GAS) was used to evaluate the functional outcome of each treatment session.

Results

In the first study, the mean GAS score of the total group was 51.7 (±7.5). Considering a converted total score of 50 as cut-off score for successful treatment, 67.1 % of the treatments were successful. Significantly higher GAS scores were found in mildly involved children compared to more involved children (p < 0.0001) and for multilevel injections or injections in the distal muscle groups only compared to injections in the proximal muscles of the lower limb only (p < 0.0001). Other crucial factors for a successful outcome were amount of physical therapy per week (p=0.0026), post injection casting (p=0.005) and frequency of using day and night orthoses after injection (p < 0.0001). In the second study, the mean GAS score of the total group decreased from 54.8 (±6.8) at the first treatment to 50.7 (±6.9) at the last treatment, indicating that on average, repeated BTX-A treatment is successful.

Conclusion

The integrated multilevel BTX-A approach is successful in children with CP. Several factors might help the clinician to select patients that are most likely to benefit from the treatment, to assure the most optimal treatment strategy and to predict the outcome. Each treatment should be carefully planned and goals should be well chosen, because the effectiveness of the BTX-A treatment may decrease with increasing number of treatments in the same patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Aoki KR (2003) Pharmacology and immunology of botulinum toxin type A. Clin Dermatol 21:476–480

    Article  Google Scholar 

  2. Aoki KR, Ranoux D, Wissel J (2006) Using translational medicine to understand clinical differences between botulinum toxin formulations. Eur J Neurol 13:10–19

    Article  Google Scholar 

  3. Schroeder AS, Ertl-Wagner B, Britsch S, Schröder JM, Nikolin S, Weis J, Müller-Felber W, Koerte I, Stehr M, Berweck S, Borggraefe I, Heinen F (2009) Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers. Mov Disord 24(10):1494–1503

    Article  Google Scholar 

  4. Cans C (2000) Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol 42:816–824

    Article  Google Scholar 

  5. Reid SM, Carlin JB, Reddihough DS (2010) Distribution of motor types in cerebral palsy: how do registry data compare? Dev Med Child Neurol 53(3):233–238

    Article  Google Scholar 

  6. Molenaers G, Van Campenhout A, Fagard K, De Cat J, Desloovere K (2010) The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb. J Child Orthop 4(3):183–195

    Article  Google Scholar 

  7. Lee J, Sung I, Yoo J, Park E, Park S (2009) Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantar flexor: a randomized control trial. J Rehab Med 41:740–745

    Article  Google Scholar 

  8. Lukban M, Rosales R, Dressler D (2009) Effectiveness of botulinum toxin A for upper and lower limb spasticity children with cerebral palsy: a summary of evidence. J Neural Transm 116:319–331

    Article  CAS  Google Scholar 

  9. Bjornson K, Hays R, Graubert C, Price R, Won F, McLaughlin JF, Cohen M (2007) Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation. Pediatrics 120(1):49–58

    Article  Google Scholar 

  10. Desloovere K, Molenaers G, De Cat J, Pauwels P, Van Campenhout A, Ortibus E, Fabry G, De Cock P (2007) Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy. Dev Med Child Neurol 49(1):56–61

    Article  Google Scholar 

  11. Scholtes V, Dallmeijer A, Knol D, Speth LA, Maathuis CG, Jongerius PH, Becher JG (2007) Effect of multilevel botulinum toxin A and comprehensive rehabilitation on gait in cerebral palsy. Pediatr Neurol 36(1):30–39

    Google Scholar 

  12. Desloovere K, Molenaers G, Feys H, Huenaerts C, Callewaert B, Van de Walle P (2006) Do dynamic and static clinical measurements correlate with gait analysis parameters in children with cerebral palsy? Gait Posture 24(3):302–13

    Google Scholar 

  13. Heinen F, Desloovere K, Schroeder AS, Berweck S, Borggraefe I, van Campenhout A, Andersen GL, Aydin R, Becher JG, Bernert G, Caballero IM, Carr L, Valayer EC, Desiato MT, Fairhurst C, Filipetti P, Hassink RI, Hustedt U, Jozwiak M, Kocer SI, Kolanowski E, Krägeloh-Mann I, Kutlay S, Mäenpää H, Mall V, McArthur P, Morel E, Papavassiliou A, PascualPascual I, Pedersen SA, Plasschaert FS, Van der Ploeg I, Remy-Neris O, Renders A, Di Rosa G, Steinlin M, Tedroff K, Valls JV, Viehweger E, Molenaers G (2010) The updated European Consensus 2009 on the use of botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 14:45–66

    Google Scholar 

  14. Childers MK (1997) Rationale for localized injection of botulinum toxin type A in spasticity. Eur J Neurol 4:S37–S40

    Google Scholar 

  15. Childers M (2004) Targeting the neuromuscular junction in skeletal muscles. Am J Phys Med Rehabil 83:S38–S44

    Article  Google Scholar 

  16. Van Campenhout A, Molenaers G (2010) Localization of the motor endplate zone in human skeletal muscles of the lower limb: anatomical guidelines for injection with botulinum toxin. Dev Med Child Neurol 53(2):108–119

    Article  Google Scholar 

  17. Desloovere K, Schörkhuber V, Fagard K, Van Campenhout A, De Cat J, Pauwels P, Ortibus E, De Cock P, Molenaers G (2012) Botulinum toxin type A treatment in children with cerebral palsy: evaluation of treatment success or failure by means of goal attainment scaling. Eur J Paediatr Neurol 16(3):229–236

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatric Orthopaedics, UZ Pellenberg, Leuven, Belgium

    Guy Molenaers & Anja Van Campenhout

  2. Musculoskeletal Sciences, KU Leuven, Leuven, Belgium

    Guy Molenaers & Anja Van Campenhout

  3. Clinical Motion Analysis Laboratory, UZ Pellenberg, Belgium

    Katrien Fagard & Kaat Desloovere

  4. Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium

    Kaat Desloovere

Authors
  1. Guy Molenaers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katrien Fagard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anja Van Campenhout
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kaat Desloovere
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guy Molenaers.

About this article

Cite this article

Molenaers, G., Fagard, K., Van Campenhout, A. et al. Botulinum toxin A treatment of the lower extremities in children with cerebral palsy. J Child Orthop 7, 383–387 (2013). https://doi.org/10.1007/s11832-013-0511-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11832-013-0511-x

Keywords

Search

Navigation